Home / Investors / Financial calendar
Investors

Financial calendar

Upcoming Events

January10 – February28,2025
Muttenz Switzerland
Quiet period prior to the publication of the Fourth Quarter / Full Year 2024 Reporting
Clariant limits its communication with the capital market
Clariant limits its communication with the capital market 
February 28, 2025
Muttenz Switzerland
Fourth Quarter / Full Year 2024 Reporting
Investor event
Investor event 
March 03, 2025
Zurich Switzerland
Full Year Results Roadshow Zurich
Investor event
Investor event 
March 04, 2025
Frankfurt Germany
Full Year Results Roadshow Frankfurt
Investor event
Investor event 
March 07, 2025
Muttenz Switzerland
Publication of Integrated Report 2024
 
March 12, 2025
London United Kingdom
BNP Paribas Chemicals Conference
Investor event
Investor event 
March 13, 2025
London United Kingdom
GS European Chemicals and Ingredients Forum
Investor event
Investor event 
March 25, 2025
London United Kingdom
JPM Chemicals Forum
Investor event
Investor event 
March 26, 2025
London United Kingdom
Jeffries Pan-European Mid-Cap Conference
Investor event
Investor event 
April 01, 2025
Basel Switzerland
Annual General Meeting
Shareholder event
Shareholder event 
April 29, 2025
Muttenz Switzerland
First Quarter Reporting 2025
Investor event
Investor event 
May 28, 2025
Frankfurt Germany
dbAccess European Champions Conference
Investor event
Investor event 
July 31, 2025
Muttenz Switzerland
Second Quarter / First Half Year Reporting 2025
Investor event
Investor event 
October 30, 2025
Muttenz Switzerland
Third Quarter / Nine Month Reporting 2025
Investor event
Investor event 

Past Events

Latest Ad Hoc Announcements​

Ad hoc announcements pursuant to Art. 53 LR​

{{publicationDate}}
{{title}}
{{description}}
Learn more
{{publicationDate}}
{{title}}
{{description}}
Learn more
{{publicationDate}}
{{title}}
{{description}}
Learn more
News
Subscribe to media releases
Subscribe

Contact Us

Clariant’s Investor Relations team is committed to an open and fair dialogue with all of its stakeholders. Please contact us.

Contact Investor Relations

          Page summary

          close
          Summarization in progress
          The page summary is generated by AI